Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Account Payables (2022 - 2025)

Gossamer Bio's Change in Account Payables history spans 4 years, with the latest figure at $4.8 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 56.56% year-over-year to $4.8 million; the TTM value through Dec 2025 reached -$2.7 million, down 65.88%, while the annual FY2025 figure was -$2.7 million, 65.88% down from the prior year.
  • Change in Account Payables reached $4.8 million in Q4 2025 per GOSS's latest filing, up from -$795000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.8 million in Q4 2025 to a low of -$5.8 million in Q2 2025.
  • Average Change in Account Payables over 4 years is -$139125.0, with a median of -$651000.0 recorded in 2023.
  • Peak YoY movement for Change in Account Payables: soared 1395.44% in 2023, then tumbled 339.08% in 2024.
  • A 4-year view of Change in Account Payables shows it stood at $285000.0 in 2022, then skyrocketed by 1395.44% to $4.3 million in 2023, then decreased by 27.73% to $3.1 million in 2024, then skyrocketed by 56.56% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Change in Account Payables are $4.8 million (Q4 2025), -$795000.0 (Q3 2025), and -$5.8 million (Q2 2025).